Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation
Phase of Trial: Phase III
Latest Information Update: 06 Jul 2017
At a glance
- Drugs Granisetron (Primary) ; Granisetron (Primary) ; Ondansetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 27 Mar 2012 Status changed from not yet recruiting to recruiting as reported by M.D. Anderson Cancer Center.
- 27 Mar 2012 New source identified and integrated (M.D. Anderson Cancer Center record, 2011-1107).
- 27 Mar 2012 Actual initiation date (23 Mar 2012) added as reported by M.D. Anderson Cancer Center.